These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 7191259)

  • 1. Penbutolol: comparison of its antihypertensive effect with that of alpha-methyldopa in patients with primary hypertension.
    Vierhapper H; Dudczak R; Waldhäusl W
    Arzneimittelforschung; 1980; 30(6):1008-11. PubMed ID: 7191259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [On the pharmacology of the beta-receptor blocker penbutolol (author's transl)].
    Kaiser J; Härtfelder G; Lindner E; Schölkens B
    Arzneimittelforschung; 1980; 30(3):420-7. PubMed ID: 6992788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of penbutolol (Hoe 893d) (beta adrenergic blocker), alone and in combination with hydrochlorothiazide, in the treatment of arterial hypertension. II. Effect on plasma electrolytes, renal function, plasma renin and aldosterone activity and risk factors, including plasma lipids].
    Ocón J; Piña C; Castellet R; Vila R; del Río G; Arnau C
    Med Clin (Barc); 1985 Jun; 85(2):53-7. PubMed ID: 3894828
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of essential mild-to-moderate arterial hypertension with once-daily penbutolol. Controlled clinical study vs atenolol].
    Nami R; Martinelli M; Bianchini C; Gennari C
    Minerva Med; 1988 Nov; 79(11):965-71. PubMed ID: 3059235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise.
    Hansson BG; Hökfelt B
    Eur J Clin Pharmacol; 1975 Oct; 9(1):9-19. PubMed ID: 9298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Validity of the use of penbutolol in essential arterial hypertension].
    Pepe S; Scalici G; D'Angelo A; Curiale B; Corrao S; Agnello C
    Minerva Med; 1990 Jun; 81(6):471-3. PubMed ID: 2359502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term hemodynamic effects of penbutolol at rest and during exercise in essential hypertension.
    Lund-Johansen P
    Eur J Clin Pharmacol; 1979 Sep; 16(3):149-53. PubMed ID: 499314
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of penbutolol on the hemodynamics in patients with hypertensive disease].
    Demin AA; Mitrokhin VE
    Farmakol Toksikol; 1986; 49(5):74-6. PubMed ID: 3770181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longterm treatment of hypertension with penbutolol.
    Kundu SC; Bhattacherjee TD; Banerjee D; Nandi JS
    J Assoc Physicians India; 1984 Jun; 32(6):473-5. PubMed ID: 6511719
    [No Abstract]   [Full Text] [Related]  

  • 10. Penbutolol (Hoe 893d) in primary hypertension. Blood pressure effects, tolerance and plasma concentrations.
    Ohman KP; Asplund J; Landahl S; Liander B
    Eur J Clin Pharmacol; 1982; 22(2):95-9. PubMed ID: 7047173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of the exercise test in the differentiated treatment of patients with hypertension].
    Liusov VA; Bakhshaliev AB; Ibragimov MA
    Klin Med (Mosk); 1988 Oct; 66(10):64-8. PubMed ID: 3236786
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of penbutolol (HOE 893 d), a non-selective beta blocker, in the control of essential arterial hypertension].
    Calle Pascual AL; Charro Salgado AL
    Med Clin (Barc); 1983 Feb; 80(5):201-3. PubMed ID: 6855302
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of oral penbutolol on renal haemodynamics of hypertensive patients with renal insufficiency.
    Bailey RR; Carlson RV; Walker RJ; Swainson CP
    N Z Med J; 1985 Aug; 98(785):683-5. PubMed ID: 3863029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-blind comparison of penbutolol and long-acting propranolol in general practice.
    Hayes G
    Pharmatherapeutica; 1983; 3(7):456-63. PubMed ID: 6366804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of penbutolol and a fixed combination of penbutolol with furosemide in the treatment of hypertension.
    Haeringer E; Graml W; Rangoonwala B; Roessner M
    Pharmatherapeutica; 1982; 3(4):233-42. PubMed ID: 7146039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dose-effect comparison of antihypertensive combinations with and without alpha-methyldopa].
    Krämer KD; Ghabussi P; Lehmann HU; Hochrein H
    MMW Munch Med Wochenschr; 1975 Apr; 117(14):579-82. PubMed ID: 806789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonism.
    Frishman WH; Covey S
    J Clin Pharmacol; 1990 May; 30(5):412-21. PubMed ID: 2189902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The new beta blocker Betapressin. Long-term experience in hypertensive patients in ambulatory care].
    Dameris W
    ZFA (Stuttgart); 1981 Mar; 57(8):628-32. PubMed ID: 6111871
    [No Abstract]   [Full Text] [Related]  

  • 19. [The pharmacological effect of betapressin in hypertension].
    Zaslavskaia RM; Akhmetov KZh; Gol'denberg VA; Lilitsa GV
    Eksp Klin Farmakol; 1996; 59(6):23-5. PubMed ID: 9181866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of penbutolol (Hoe, 893 d) (beta adrenergic blockader), alone and in combination with hydrochlorothiazide, in the treatment of arterial hypertension. I: Effect on arterial hypertension. Comparative study of 2 parallel groups with crossed sequences by the simple-blind method].
    Ocón J; Piña C; del Río G
    Med Clin (Barc); 1985 Jun; 85(1):13-6. PubMed ID: 4021602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.